Cellular and molecular neurosurgery: Pathways from concept to reality - Part I: Target disorders and concept approaches to gene therapy of the central nervous system

Neurosurgery

Volumn 40, Issue 4, 1997, Pages 789-804

  Zlokovic, Berislav V ^a,b   Apuzzo, Michael L J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b RMR 506 ^*  (United States)

Author keywords

Alzheimer's disease; Brain tumor; Gene therapy; Molecular genetics; Molecular neurosurgery; Parkinson's disease; Stroke

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MONOCLONAL ANTIBODY; VIRUS VECTOR;

ADOPTIVE IMMUNOTHERAPY; ALZHEIMER DISEASE; BRAIN TUMOR; CELL TRANSPLANTATION; DEGENERATIVE DISEASE; DRUG RESISTANCE; ENZYME DEFICIENCY; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; STROKE; SUICIDE GENE;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN DISEASES, METABOLIC; BRAIN NEOPLASMS; BRAIN TISSUE TRANSPLANTATION; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROVASCULAR DISORDERS; DNA, RECOMBINANT; DRUG RESISTANCE; ENZYMES; FETAL TISSUE TRANSPLANTATION; GENE THERAPY; GENETIC DISEASES, INBORN; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MICE; MICE, KNOCKOUT; NEUROSURGERY; OLIGONUCLEOTIDES, ANTISENSE; PARKINSON DISEASE; STEM CELL TRANSPLANTATION; TRANSFECTION; TRANSGENES;

EID: 0030933273     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199704000-00027     Document Type: Review

References (106)

1. Akbasak A, Oldfield EH, Saris SC: Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro. J Neurosurg 75:922-929, 1991.
2. Betz AL, Yang G-Y, Davidson BL: Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 15:547-551, 1995.
3. 2a. Bi WL, Parysek LM, Warnick R, Stambrook PJ: In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV-tk retroviral gene therapy. Hum Gene Ther 4:725-731, 1993.
4. Bodmer S, Huber D, Heid I, Fontana A: Human glioblastoma cell derived transforming growth factor-β2: Evidence for secretion of both high and low molecular weight biologically active forms. J Neuroimmunol 34:33-12, 1991.
5. Bolovan CA, Sawtell NM, Thompson RL: ICP 34.5 mutants of herpes simplex virus Type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J Virol 68:48-55, 1994.
6. Boussif O, Lezoualch F, Zanta HA, Mergny MD, Scherman D, Demeneix B, Behr JP: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethyleninine. Proc Natl Acad Sci U S A 92:7297-7301, 1995.
7. Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO, Chiocca EA: Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res 54:5745-5751, 1994.
8. Cao L, Zheng ZC, Zhao YC, Jiang ZH, Liu ZG, Chen SD, Zhou CF, Liu XY: Gene therapy of Parkinson's disease model rat by direct injection of plasmid DNA-lipofectin complex. Hum Gene Ther 6:1497-1501, 1995.
9. Carmeliet P, Collen D: Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system. Thromb Haemost 74:429-436, 1995.
10. Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC: Plasminogen activator inhibitor-1 gene-deficient mice: I - Generation by homologous recombination and characterization. J Clin Invest 92:2746-2755, 1993.
11. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, DeVos R, van den Oord JJ, Collen D, Mulligan R: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-124, 1994.
12. Carmeliet P, Stassen JM, Cullen D, Meidell R, Gerard R: Adenovirus-mediated gene transfer of rt-PA restores thrombolysis in t-PA deficient mice. Fibrinolysis 8:282, 1994 (abstr).
13. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D: Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci U S A 93:7024-7028, 1993.
14. Cesano A, Visonneau S, Santoli D: Treatment of experimental glioblastoma with a human major histocompatibility complex nonrestricted cytotoxic T-cell line. Cancer Res 55:96-101, 1995.
15. Chambers R, Gillespie GY, Soroceanu L, Andreansky S, Chatterjee S, Chou J, Roizman B, Whitley RJ: Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a SCID mouse model of human malignant glioma. Proc Natl Acad Sci U S A 54:1411-1415, 1995.
16. Chen CH, Chang YN, Ryan P, Linscott M, McGarrity GJ, Chiang YL: Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect." Hum Gene Ther 6:1467-1476, 1995.
17. Chen SH, Shine HD, Goodman JC, Grossman RF, Woo SLC: Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci U S A 91:3054-3057, 1994.
18. Chou J, Kern ER, Whitley RJ, Roizman B: Mapping of herpes simplex virus neurovirulence to gamma 1 34.5, a gene nonessential for growth in culture. Science 250:1262-1266, 1990.
19. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-produced cells for treatment of experimental brain tumors. Science 256:1550-1552, 1992.
20. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ: A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet 3:219-223, 1993.
21. During MJ, Naegele JR, O'Malley KL, Geller AI: Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399-1403, 1994.
22. Elledge SJ Harper JW: CDK inhibitors on the threshold of checkpoints and development. Curr Opin Cell Biol 6:874-878, 1994.
23. Ellis R, Yuan J, Horvitz H: Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663-698, 1991.
24. Ezzeddine ZT, Martuza RL, Platika D, Short MP, Malick A, Choi B, Breakefield XO: Selective killing of glioma cells in culture and in vivo by retroviral transfer of the herpes simplex virus thymidine kinase gene. N Biol 3:608-614, 1991.
25. Fakhrai H, Dorig O, Shawler D, Lin H, Mercola D, Black K, Royston I, Sobol R: Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy. Proc Natl Acad Sci U S A 93:2909-2914, 1996.
26. Fenstermaker R, Capala J, Barth R, Hujer A, Kung H-J, Kaetzel D: The effect of epidermal growth factor receptor (EGFR) expression on in vivo growth of rat C6 glioma cells. Leukemia 9[Suppl 1]:S106-S112, 1995.
27. Feuerstein G, Liu T, Barone FC: Cytokines, inflammation and the brain: The role of TNFα. Cerebrovasc Brain Metab Rev 6:341-360, 1994.
28. Fleischman RA: Southwestern internal medicine conference: Human gene therapy. Am J Med Sci 301:353-363, 1991.
29. Freed CR, Breeze RE, Rosenberg NL, Schneck SA: Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease: Replacing failed nerve terminals. Adv Neurol 60:721-728, 1993.
30. Gage FH, Kawaja MD, Fisher LJ: Genetically modified cells: Applications for intracerebral grafting. Trends Neurosci 14:328-333, 1991.
31. Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, Frangione B: Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol 145:526-530, 1994.
32. Ghiso J, Wisniewski T, Frangione B: Unifying features of systemic and cerebral amyloidosis. Mol Neurobiol 8:49-64, 1994.
33. Gordon EM, Anderson WF: Gene therapy using retroviral vectors. Curr Opin Biotech 5:611-616, 1994.
34. Groves AK, Barnett SC, Franklin RJ, Crang AJ, Mayer M, Blakemore WF, Noble M: Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells. Nature 362: 453-455, 1993.
35. Hall FL, Vallet PR: Proline-directed protein phosphorylation and cell cycle regulation. Curr Opin Cell Biol 3:176-184, 1991.
36. Hunter T, Pine J: Cyclins and cancer. Cell 66:1071-1074, 1991.
37. Hunter T, Pine J: Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79:573-582, 1994.
38. Johnson EJ, Deckwerth T: Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci 16:31-46, 1993.
39. Kane D, Sarafian T, Anton R, Hahn H, Gralla E, Selverstone V, Ord T, Bredesen D: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262:1274-1277, 1993.
40. Kittaka M, Wang L, Sun N, Schreiber SS, Seeds NW, Fisher M, Zlokovic BV: Brain capillary tissue plasminogen activator in a diabetes stroke model. Stroke 27:712-719, 1996.
41. Koc ON, Allay JA, Lee K, Davis BM, Reese JS, Gerson SL: Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance. Semin Oncol 23:46-65, 1996.
42. Lacorazza HD: Expression of human β-hexosaminidase α-subunit gene (the gene defect of Tay-Sachs Disease) in mouse brains upon engraftment of transduced progenitor cells. Nature Med 2:424-429, 1996.
43. Leinekugel P, Michel S, Conzelmann E, Sandhoff K: Quantitative correlation between the residual activity of hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88:513-523, 1992.
44. LeMay DR, Kittaka M, Gordon EM, Anderson WF, McComb JG, Weiss MH, Bartus R, Zlokovic BV: RMP-7 effect and the role of the blood-brain barrier on ganciclovir treatment in a rat model of C6 glioma transduced with herpes thymidine kinase gene. Presented at the 46th Annual Meeting of the Congress of Neurological Surgeons, Montreal, Canada. September 28-October 3, 1996 (abstr).
45. Levivier M, Przedborski S, Bencsics C, Kang UJ: Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor of Parkinson's disease. J Neurosci 15:7810-7820, 1995.
46. Levy E, Carman MD, Fernandez-Madirid I, Liebergurg I, Power MD, vanDuinen SG, Bots GRAM, Luyendijk W, Frangione B: Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124-1126, 1990.
47. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Shima J, Pettingell WH, Chang-en Y, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu YH, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977, 1995.
48. Deleted in proof.
49. Linnik MD, Zahos P, Geschwind MD, Federoff HJ: Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 26:1670-1675, 1995.
50. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, Schulze-Osthoff K: Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature 375:81-83, 1995.
51. Lundberg C, Horellou P, Mallet J, Bjorklund A: Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: In vitro characterization and in vivo effects in the rat Parkinson model. Exp Neurol 139:39-53, 1996.
52. M2-gangliosidosis. Biochim Biophys Acta 1096: 87-94, 1991.
53. Markert JM, Malick A, Coen DM, Martuza RL: Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery 32:597-603, 1993.
54. Martel CL, Mackic JB, McComb JG, Ghiso J, Zlokovic BV: Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs. Neurosci Lett 206:157-160, 1996.
55. Martinez-Serrano A, Lundberg C, Horellou P, Fischer W, Bentlage C, Campbell K, McKay RD, Mallet J, Bjorklund A: CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: Complete rescue of axotomized cholinergic neurons after transplantation in to the septum. J Neurosci 15:5668-5680, 1995.
56. Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM: Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252:854-856, 1991.
57. Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades HN: Effect of the expression of transforming growth factor-β2 in primary human glioblastomas on immunosuppression and loss of immune surveillance. J Neurosurg 76:799-804, 1992.
58. Miller AD, Rosman G: Improved retroviral vectors for gene transfer and expression. Biotechnology 7:980-990, 1989.
59. Moolten FL, Wells JM: Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297-300, 1990.
60. Moolten FL, Wells JM, Heyman RA, Evans RM: Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum Gene Ther 1:125-134, 1990.
61. Neuwelt EA, Pagel MA, Geller A, Muldoon LL: Gene replacement therapy in the central nervous system: Viral vector-mediated therapy of global neurodegenerative disease. Behav Brain Sci 18:1-9, 1995.
62. Oldfield EH, Ram Z, Culver KW, Blease RM, Devroom HL, Anderson WF: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 4:39-69, 1993.
63. Olsen I, Muir H, Smith R, Fensom A, Watt DJ: Direct enzyme transfer from lymphocytes is specific. Nature 306:75-77, 1983.
64. Oppenheim RW: Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501, 1991.
65. Palella TD, Silverman LJ, Schroll CT, Homa FL, Levin M, Kelley WN: Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells. Mol Cell Biol 8:457-460, 1988.
66. Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SL, Grossman RG, Shine HD: Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res 39:506-511, 1995.
67. Peter M, Herskowitz I: Joining the complex cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184, 1994.
68. Pincus DW, Harrison C, Barry J, Goodman RR, Labar D, Fraser RAR, Nedergaard M, Goldman SA: In vitro generation of precursor-derived neurons from adult human epileptic temporal neocortex. Presented at the 46th Annual Meeting of the Congress of Neurological Surgeons, Montreal, Canada. September 28-October 2, 1996 (abstr).
69. Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S: Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc Natl Acad Sci USA 92:12260-12264, 1995.
70. Ram Z, Culver K, Oshiro E, Viola J, DeVroom H, Otto E, Long Z, McGarrity G, Muul L, Katz D, Blease RM: Summary of results and conclusions of the gene therapy of malignant brain tumors: Clinical study. J Neurosurg 82:343A, 1995 (abstr).
71. Ram Z, Culver KW, Walbridge S, Frank JA, Blease RM, Oldfield EH: Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J Neurosurg 79:400-407, 1993.
72. Ram Z, Walbridge S, Oshiro EM, Viola JJ, Chiang Y, Mueller SN, Blease RM, Oldfield EH: Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res 54:2141-2145, 1994.
73. Randazzo BP, Kesari S, Gesser RM, Alsop D, Ford JC, Brown SM, Maclean A, Fraser NW: Treatment of experimental intracranial murine melanoma with a neuro attenuated herpes simplex virus 1 mutant. Virology 211:94-101, 1995.
74. Redekop GJ, Naus CC: Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. J Neurosurg 82:83-90, 1995.
75. Regulatory Issues. Hum Gene Ther 6:1065-1124, 1995.
76. Rogaev E, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacimias B, Placentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St. George-Hyslop P: Familial Alzheimer's disease in kindreds with missense mutations in a gene on Chromosome 1 related to the Alzheimer's disease Type 3 gene. Nature 376:775-778, 1995.
77. Roszman T, Elliott L, Brooks W: Modulation of T-cell function by gliomas. Immunol Today 12:370-374, 1991.
78. Rothwell NJ, Relton JK: Involvement of interleukin-1 and lipocortin-1 in ischemic brain damage. Cerebrovasc Brain Metab Rev 5:178-198, 1993.
79. Rubin JT, Lotze MT: Adoptive cellular immunotherapy of cancer, in Mitchell MS (ed): Biological Approaches to Cancer Treatment: Biomodulation. New York, McGraw-Hill Inc., 1993, pp 379-410.
80. Sabate O, Horellou P, Vigne E, Colin P, Perricaudet M, Buc-Caron MH, Mallet J: Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nature Genet 9:256-260, 1995.
81. Saleh M, Stacker SA, Wilks AF: Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56:393-401, 1996.
82. Saris SC, Spiess P, Lieberman DM, Lin S, Walbridge S, Oldfield EH: Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes. J Neurosurg 76:513-519, 1992.
83. Schneider J, Hofman FM, Apuzzo MLJ, Hinton DR: Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg 77:265-273, 1992.
84. Scolding NJ, Rayner PJ, Sussman J, Shaw C, Compston DA: A proliferative adult human oligodendrocyte progenitor. Neuroreport 6:441-445, 1995.
85. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, DaSilva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop P: Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 375:754-760, 1995.
86. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y: Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374:811-813, 1995.
87. Skotzko M, Wu L, Anderson WF, Gordon EM, Hall FL: Retroviral vector-mediated gene transfer of antisense cyclin G1 (GYCG1) inhibits proliferation of human osteogenic sarcoma cells. Cancer Res 55:5493-5498, 1995.
88. Snyder EY, Taylor RM, Wolfe JH: Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374:367-370, 1995.
89. Spencer DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS, Sass KJ, Elsworth JD, Kier EL, Makuch R, Hoffer PB, Redmond DE Jr: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541-1548, 1992.
90. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huange DY, Pericak-Vance M, Schmechel D, Roses AD: Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer's disease. Proc Natl Acad Sci U S A 91:11183-11186, 1994.
91. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of Type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci U S A 90:1977-1981, 1993.
92. Takamiya Y, Short MP, Ezzeddine ZT, Moolten FL, Breakefield XO, Martuza RL: Gene therapy of malignant brain tumors: A rat glioma line bearing the herpes simplex virus Type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 33:493-503, 1992.
93. Torre-Amione G, Beauchamp RD, Kowppen H, Park BH, Schreiber H, Moses HL, Rowley DA: A highly immunogenic tumor transfected with a murine transforming growth factor Type β1 cDNA escapes immune surveillance. Proc Natl Acad Sci U S A 87:1486-1490, 1990.
94. Trojan J, Johnson TR, Rudlin SD, Ilan J, Tykocinski ML, Ilan J: Treatment and prevention of rat glioblastoma by C6 cells expressing antisense IGF-I RNA. Science 259:94-97, 1993.
95. Van Broeckhoven CL: Presenilins and Alzheimer's disease. Nature Genet 11:230-232, 1995.
96. Vincent AJPE, Vogels R, Someren GV, Esandi MC, Noteboom JL, Avezaat CJJ, Vecht C, Bekkum DWV, Valerio D, Bout A, Hoogerbrugge PM: Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Hum Gene Ther 7:197-205, 1996.
97. Wang L, Kittaka M, Sun N, Schreiber SS, Zlokovic BV: Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats. J Cereb Blood Flow Metab (in press).
98. Wels W, Moritz D, Schmidt M, Jeschke M, Hynes NE, Groner B: Biotechnological and gene therapeutic strategies in cancer treatment. Gene 159:73-80, 1995.
99. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Bjorklund A, Lindvall O, Langston JW: Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 327:1556-1563, 1992.
100. Wolfe JH, Deshmane SL, Fraser NW: Herpesvirus vector gene transfer and expression of glucuronidase in the central nervous system of MPS VII mice. Nature Genet 1:379-384, 1992.
101. Wolff JA, Fisher LJ, Xu L, Jinnah HA, Langlias PJ, Iuvone PM, O'Malley KL, Rosenberg MB, Shimohama S, Friedmann T, Gage FH: Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson's disease. Proc Natl Acad Sci USA 86:9011-9014, 1989.
102. Yoshimoto Y, Lin Q, Collier TJ, Frim DM, Breakefield XO, Bohn MC: Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in rat model of Parkinson's disease. Brain Res 691:25-36, 1995.
103. Zlokovic BV: Cerebrovascular transport of Alzheimer's amyloid-β and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier. Life Sci 59:1483-1497, 1996.
104. Zlokovic BV, Apuzzo MLJ: Cellular and molecular neurosurgery: Pathways from concept to reality - Part II: Vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery 40:805-813, 1997.
105. Zlokovic BV, Martel CL, Matsubara E, McComb JG, Zheng G, McCluskey RT, Frangione B, Ghiso J: Glycoprotein 330/megalin: Probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer's disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci U S A 93:4229-4234, 1996.
106. Zlokovic BV, Wang L, Sun N, Haffke S, Verrall S, Seeds NW, Fisher MJ, Schreiber SS: Expression of tissue plasminogen activator in cerebral capillaries: Possible fibrinolytic function of the blood-brain barrier. Neurosurgery 37:955-961, 1995.